Sort
85,873 grants matching “alzheimers”
The Long Life Family Study
$15,390,755Michael A Province · Washington University · U19 · FY2020 · AG
Johns Hopkins Institute for Clinical and Translational Research
$15,388,930Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2019 · TR
Alzheimer's Prevention Initiative
$15,252,950Eric M Reiman · Banner Alzheimer'S Institute · RF1 · FY2012 · AG
The Long Life Family Study
$15,098,513Michael A Province · Washington University · U19 · FY2025 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
$15,000,000Susan Abushakra · Alzheon, Inc. · R01 · FY2020 · AG
DIAN-TU: Tau Next Generation Prevention Trial
$14,975,441Randall J Bateman · Washington University · R01 · FY2021 · AG
DIAN-TU: Tau Next Generation Prevention Trial
$14,973,241Randall J Bateman · Washington University · R01 · FY2020 · AG
Alzheimer's Disease Neuroimaging Initiative
$14,780,250Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2017 · AG
A multimodal brain cell atlas and community resource of Alzheimer's disease and comorbid dementias.
$14,713,224Ed Lein · Allen Institute · U19 · FY2025 · AG
MRI Measures of Cerebrovascular Injury and AD Atrophy in a Study of Latinos
$14,695,967Charles Decarli · University Of California At Davis · RF1 · FY2017 · AG
Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months
$14,619,478Anthony O Caggiano · Cognition Therapeutics, Inc. · R01 · FY2021 · AG
Amyloid Imaging, VMCI, and Analysis for ADNI
$14,561,106Michael W Weiner · Northern California Institute/Res/Edu · RC2 · FY2010 · AG
The Long Life Family Study
$14,534,752Michael A Province · Washington University · U19 · FY2021 · AG
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)
$14,499,067Adam L Boxer · University Of California, San Francisco · R01 · FY2025 · AG
BRAIN CONNECTS: A Center for High-throughput Integrative Mouse Connectomics
$14,497,158Jeff W Lichtman · Harvard University · UM1 · FY2023 · NS
HABS-HD - Core C - Clinical Core
$14,469,992Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2024 · AG
Clinical Core
$14,151,087Paul S. Aisen · Northern California Institute/Res/Edu · U19 · FY2023 · AG
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
$14,058,964Natalia S Rost · Massachusetts General Hospital · U19 · FY2021 · NS
Alzheimer's Clinical Trials Consortium (ACTC)
$14,053,120Paul S. Aisen · University Of Southern California · U24 · FY2018 · AG
Alzheimer's Clinical Trials Consortium (ACTC)
$13,976,431Paul S. Aisen · University Of Southern California · U24 · FY2019 · AG
The Human Genome Sequencing Center
$13,964,521Richard A Gibbs · Baylor College Of Medicine · U54 · FY2013 · HG
Clinical Core
$13,964,403Paul S. Aisen · Northern California Institute/Res/Edu · U19 · FY2025 · AG
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
$13,954,895Natalia S Rost · Massachusetts General Hospital · U19 · FY2023 · NS
Early Onset AD Consortium - the LEAD Study (LEADS)
$13,904,119Liana G Apostolova · Indiana University Indianapolis · U01 · FY2023 · AG
Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease
$13,828,710Jane S Paulsen · University Of Wisconsin-Madison · RF1 · FY2021 · AG